Krystal Biotech, Inc. 10-Q

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS The following table summarizes information with respect to purchases of our equity securities during the three months ended March 31, 2024: Period Total number of shares (or units) purchased Average price paid per share (or unit) Total number of shares (or units) purchased as part of publicly announced plans or programs Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs January 1, 2024 - January 31, 2024 — — — February 1, 2024 - February 28, 2024 7,677 $ 78.89 — — March 1, 2024 - March 31, 2024 — — — Total 7,677 (1) $ 78.89 — — (1) Represents shares withheld from employees for taxes resulting from the vesting of restricted stock awards. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. MINE SAFETY DISCLOSURES Not applicable.